SIONSionna Therapeutics, Inc.

$51.04

Who owns SION

122 institutions reported holding SION for 2026Q1, together 101% of the company, more than the 100 a quarter earlier.

122

Institutions reporting a position · as of 2026Q1 · up from 100 the quarter before

Shares held by institutions
45.4M

Shares held by institutions · 101% of the company · long US equity positions only, as reported on Form 13F

Reported value
$1.82B

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
58%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
5
New positions
28
Positions exited
10
Added to
39
Reduced
29
Top 10 holdersof the company
76%
Institutional ownership by quarter, 2025Q1 to 2026Q1
QuarterFilersSharesReported value
2026Q112245.4M$1.82B
2025Q410043.9M$1.81B
2025Q37842.8M$1.26B
2025Q26543.4M$754M
2025Q14741.5M$434M
Largest reported holders, 2026Q1
HolderShares% of companyValue
RA CAPITAL MANAGEMENT, L.P.9.9M22%$397M
TPG GP A, LLC6.5M14%$260M
ORBIMED ADVISORS LLC3.5M7.9%$142M
VIKING GLOBAL INVESTORS LP3.2M7.1%$128M
Atlas Venture Life Science Advisors, LLC3.0M6.7%$120M
ENAVATE SCIENCES GP, LLC2.5M5.5%$99M
JPMORGAN CHASE & CO1.5M3.3%$54M
JENNISON ASSOCIATES LLC1.5M3.2%$58M
BlackRock Inc.1.3M2.9%$52M
VANGUARD GROUP INC1.3M2.9%$52M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…